Celebrex Users vs. Pharmacia Corp.

On December 15, 2004 Pfizer Pharmaceutical announced that a recent study found an increased risk of heart disease with the pain killer Celebrex -- one of two U.S. approved Vioxx sister drugs. Pfizer said it received new information about the cardiovascular safety of its COX-2 inhibitor Celebrex (celecoxib) based on an analysis of two long-term cancer trials.

Since the withdrawal of Vioxx, there's been an upsurge of attention on Bextra and Celebrex. Like Vioxx, these drugs -- both made by Pfizer -- are in the drug class of Cox-2 inhibitors. All these drugs are effective in relieving arthritis pain. Because they have the same mechanism of action, a lot more attention is being paid to whether these drugs might also increase heart risk.

As reported to Pfizer by the Data Safety and Monitoring Board, one of the studies (the APC cancer trial) demonstrated an increased cardiovascular risk over placebo, while the other trial (the PreSAP cancer trial) revealed no greater cardiovascular risk than placebo.

Celebrex is approved for use in the United States for the treatment of arthritis and pain, at recommended doses of 100mg to 200mg daily for osteoarthritis and 200mg to 400mg a day for rheumatoid arthritis. It is also approved for a rare condition called familial adenomatous polyposis in doses up to 800mg per day. The APC cancer trial studied Celebrex at doses of 400mg to 800mg per day. In the PreSAP cancer trial the dose was 400mg per day.

If you or a loved one has suffered heart attack, stroke or serious side effect from Celebrex, or if a loved one has died while taking Celebrex, you may be entitled to monetary compensation. For a free review of your claim, please complete the Celebrex Information Form. Upon submission, your Celebrex Information Form will be evaluated by a member of our staff. That lawyer will personally evaluate your case, and may contact you to further discuss your situation. Please be advised that by submitting a Celebrex Information Form, we are not agreeing to undertake representation of you in connection with a potential claim for damages as a result of your Celebrex use. The Celebrex Information Form is being supplied solely to allow us to make an initial determination.

Please call Terri Lightner toll free at 1-877-621-1228 if you have any questions.

Click here to prepare online a confidential questionnaire. Submission of your information will enable us to make a preliminary determination of a potential claim without any cost to you.